Biotechnology

Prolacta’s human milk-based nutrition has impacted the lives of 100,000 premature and critically ill babies worldwide

by

Milestone celebrated during Prematurity Awareness Month DUARTE, California., November 17, 2023 /PRNewswire/ — Prolacta BiosciencesThe world’s leading hospital supplier of 100% breast milk nutritional products for critically ill, premature infants proudly commemorates Prematurity Awareness Month 2023 by announcing a major milestone: the lives of more than 100,000 premature and critically ill infants have been impacted … Read more